PPP6C Antibody (YA6992)
(Synonyms: FLJ92648 antibody; MGC12249 antibody; PP 6 antibody; PP6 antibody; PP6C antibody; PPP 6 antibody; PPP 6C antibody; PPP6 antibody; PPP6_HUMAN antibody; Ppp6c antibody)Based on 1 Customer Validation
PPP6C Antibody (YA6992) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PPP6C.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, ICC/IF, IHC-P, FC
-
Reactivity :
Human, Mouse
-
Formulation:
Supplied in 1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
FC
FC: Flow Cytometry
|
|---|---|---|---|---|
| Dilution Ratio | 1:500-1:2000 | 1:50 | 1:50-1:100 | 1:500-1:1000 |
Product Details
PPP6C Antibody (YA6992) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PPP6C.
-
Host Rabbit
-
Clonality Recombinant,Monoclonal
-
Species ReactivityHuman, Mouse
-
Observed Molecular WeightObserved band size: 35 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 35 kDa
Synthetic peptide within human PPP6C aa 255-305/305.
Endogenous
Protein A affinity purified.
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Liquid
-
Formulation
Supplied in 1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
PPP6C is a Catalytic subunit of protein phosphatase 6 (PP6). PP6 is a component of a signaling pathway regulating cell cycle progression in response to IL2 receptor stimulation. N-terminal domain restricts G1 to S phase progression in cancer cells, in part through control of cyclin D1. During mitosis, regulates spindle positioning. Down-regulates MAP3K7 kinase activation of the IL1 signaling pathway by dephosphorylation of MAP3K7. Also participates in the innate immune defense against viruses by desphosphorylating RIGI, an essential step that triggers RIGI-mediated signaling activation. Also regulates innate immunity by acting as a negative regulator of the cGAS-STING pathway: mediates dephosphorylation and inactivation of CGAS and STING1. CGAS dephosphorylation at 'Ser-435' impairs its ability to bind GTP, thereby inactivating it[1][2][3][4][5][6][7].
-
Subcellular Localization
Mitochondrion,Cytoplasm
-
Expression
Tissue_Specificity: Ubiquitously expressed in all tissues tested with highest expression levels in testis, heart, kidney, brain, stomach, liver and skeletal muscle and lowest in placenta, lung colon and spleen
Induction: Regulated by IL2/interleukin-2 in peripheral blood T cells -
Isoforms & Post-Translational Modification
O00743 has 3 isomers: O00743-1: 35144 Da (predicted); O00743-2: 32532 Da (predicted); O00743-3: 38947 Da (predicted).
-
Subunit
Protein phosphatase 6 (PP6) holoenzyme is proposed to be a heterotrimeric complex formed by the catalytic subunit, a SAPS domain-containing subunit (PP6R) and an ankyrin repeat-domain containing regulatory subunit (ARS) (PubMed:18186651)
-
SwissProt ID
-
Synonyms
FLJ92648 antibody; MGC12249 antibody; PP 6 antibody; PP6 antibody; PP6C antibody; PPP 6 antibody; PPP 6C antibody; PPP6 antibody; PPP6_HUMAN antibody; Ppp6c antibody
Documentation
-
Data Sheet (231 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
User Guide for Antibodies (1077 KB)